A--to expand the scope of the program by re-introducing the manufacture and distri

The primary purpose of the acquisition for the Production Assistance for Cellular Therapy (PACT) III program contract awards is to expand the scope of the program by re-introducing the manufacture and distribution of cellular products for use in human subjects participating in clinical trials under investigational new drug (IND) applications for the cell product.

• NAICS541715
• PSCA

• Click here to see more information about this opportunity on FedConnect

  Not yet available

• Williams, Jeffrey A.